BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30692037)

  • 1. Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.
    Gao M; Yao X; Ding J; Hong R; Wu Y; Huang H; Zhuang L; Li Z; Wang Y; Zhang Y; Guan Y
    J Clin Neurosci; 2019 Mar; 61():22-27. PubMed ID: 30692037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.
    Zhang Y; Yao XY; Gao MC; Ding J; Hong RH; Huang H; Zhuang L; Wang YG; Hao Y; Guan YT
    CNS Neurosci Ther; 2018 Jan; 24(1):64-69. PubMed ID: 29110391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D
    Cho EB; Shin JH; Kwon S; Kim J; Seok JM; Kim BJ; Min JH
    Front Immunol; 2021; 12():677041. PubMed ID: 34394078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.
    Min JH; Waters P; Vincent A; Cho HJ; Joo BE; Woo SY; Lee SY; Shin HY; Lee KH; Kim BJ
    PLoS One; 2014; 9(9):e107274. PubMed ID: 25211011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 25-hydroxyvitamin D
    Shan Y; Tan S; Zhang L; Huang J; Sun X; Wang Y; Cai W; Qiu W; Hu X; Lu Z
    J Neuroimmunol; 2016 Oct; 299():118-123. PubMed ID: 27725109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
    Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
    Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.
    Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W
    Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity.
    Yang CS; Zhang QX; Deng Y; Zhou BJ; Zhang LJ; Li LM; Qi Y; Wang J; Yang L; Shi FD
    BMC Neurol; 2019 Aug; 19(1):185. PubMed ID: 31382910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D status and the risk of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.
    Liu S; Tan B; Zhou J; Xiao L; Li M; Yin J
    J Clin Neurosci; 2024 Jan; 119():185-192. PubMed ID: 38113581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Status in Children With Short Stature: Accurate Determination of Serum Vitamin D Components Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Xu B; Feng Y; Gan L; Zhang Y; Jiang W; Feng J; Yu L
    Front Endocrinol (Lausanne); 2021; 12():707283. PubMed ID: 34721288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of a LC-MS/MS assay for simultaneous analysis of 25-hydroxyvitamin-D and 3-epi-25-hydroxyvitamin-D metabolites in canine serum.
    Hurst EA; Homer NZ; Denham SG; MacFarlane E; Campbell S; Boswinkel M; Mellanby RJ
    J Steroid Biochem Mol Biol; 2020 May; 199():105598. PubMed ID: 31958632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D level status in Thai neuromyelitis optica patients.
    Jitprapaikulsan J; Siritho S; Prayoonwiwat N
    J Neuroimmunol; 2016 Jun; 295-296():75-8. PubMed ID: 27235352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower serum interleukin-22 and interleukin-35 levels are associated with disease status in neuromyelitis optica spectrum disorders.
    Yang H; Han L; Zhou YJ; Ding J; Cai Y; Hong RH; Hao Y; Zhu DS; Shen XF; Guan YT
    CNS Neurosci Ther; 2020 Feb; 26(2):251-259. PubMed ID: 31342670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
    Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serum levels of endothelin-1 and disease severity in patients with neuromyelitis optica spectrum disorders.
    Yi M; Liu MQ; Chou LS; Jiang SM; Zhang LJ; Huang CN; Wang N; Zhang QX; Yang L
    Immunobiology; 2020 May; 225(3):151959. PubMed ID: 32517881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2.
    Freeman J; Wilson K; Spears R; Shalhoub V; Sibley P
    Clin Biochem; 2015 Nov; 48(16-17):1097-104. PubMed ID: 26054580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients.
    Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R
    Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
    Zhang DQ; Jia K; Wang R; Li T; Zhao N; Yang LN; Yang L
    J Neuroimmunol; 2016 Apr; 293():100-104. PubMed ID: 27049569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.